The safety of 7-valent pneumococcal conjugate vaccine (Q36190995)

12 August 2017

1 reference

title

The safety of 7-valent pneumococcal conjugate vaccine (English)

1 reference

pneumococcal conjugate vaccine

12 August 2017

main subject

1 reference

Faryal Ghaffar

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Expert Opinion on Drug Safety

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

631-636

1 reference

Bacterial meningitis in the United States in 1995. Active Surveillance Team

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Pneumococcal conjugate vaccines in Europe, Berlin, Germany, 23-25 August 2000. Report of a European advisory board meeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.4.631

21 January 2018

Identifiers

DOI

10.1517/14740338.4.4.631

1 reference

12 August 2017

1 reference